<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of the <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> 'metabotropic' receptor was investigated in an experimental model of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-induced <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The metabotropic <z:chebi fb="4" ids="48705">agonist</z:chebi>, trans-1-amino <z:chebi fb="0" ids="23492">cyclopentane</z:chebi>-1,3-<z:chebi fb="0" ids="35692">dicarboxylic acid</z:chebi> (t-ACPD, 20 mg/kg i.p.), was administered to mice immediately after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), which causes cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Seven days after MCAO, the mean <z:mpath ids='MPATH_124'>infarct</z:mpath> volume value of the t-ACPD-treated group (mean +/- S.E. = 4.57 +/- 0.73 mm3) was significantly reduced, by 34.3%, compared to the vehicle-treated group (mean +/- S.E. = 6.95 +/- 0.59 mm3, P less than 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>This suggests that metabotropic receptor activation in the adult brain reduces excitotoxicity </plain></SENT>
</text></document>